Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges

V Das, J Kalita, M Pal - Biomedicine & Pharmacotherapy, 2017 - Elsevier
Background Colorectal cancer (CRC) is one of the leading cause of cancer deaths
worldwide. Since CRC is largely asymptomatic until alarm features develop to advanced …

Plants as sources of natural and recombinant anti-cancer agents

JF Buyel - Biotechnology advances, 2018 - Elsevier
Herbal remedies were the first medicines used by humans due to the many
pharmacologically active secondary metabolites produced by plants. Some of these …

Biomarkers for personalized oncology: recent advances and future challenges

M Kalia - Metabolism, 2015 - Elsevier
Cancer is a group of diseases characterized by the uncontrolled growth and spread of
abnormal cells and oncology is a branch of medicine that deals with tumors. The last decade …

Early detection of lung cancer biomarkers through biosensor technology: A review

A Roointan, TA Mir, SI Wani, KK Hussain… - … of pharmaceutical and …, 2019 - Elsevier
Lung cancer is undoubtedly one of the most serious health issues of the 21 st century. It is
the second leading cause of cancer-related deaths in both men and women worldwide …

Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients

S Dihlmann, S Tao, F Echterdiek… - … journal of cancer, 2014 - Wiley Online Library
Functional studies on colorectal cancer cells indicated a protective role of the interferon‐
inducible dsDNA sensor Absent in Melanoma 2 (AIM2) in cancer progression. Given that a …

Accuracy of CT-guided core-needle biopsy in diagnosis of thoracic lesions suspicious for primitive malignancy of the lung: a five-year retrospective analysis

E Baratella, S Cernic, P Minelli, G Furlan, F Crimì… - Tomography, 2022 - mdpi.com
Background: Lung cancer represents a heterogeneous group of neoplasms, with the highest
frequency and mortality in both sexes combined. In a clinical scenario characterized by the …

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer

A Zaravinos, C Roufas, M Nagara… - Journal of Experimental …, 2019 - Springer
Background Microsatellite unstable colorectal cancers (MSI+ CRCs) expressing PD-L1,
respond to anti-PD-1 or anti-PD-L1 checkpoint blockade, whereas microsatellite-stable …

Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer

A Hajjafari, S Sadr, A Rahdar, M Bayat… - Inorganic Chemistry …, 2024 - Elsevier
As the third most severe cancer in the world, colorectal cancer (CRC) is of high concern to
global health concerns. Aging, unhealthy lifestyles, and genetic factors contribute to CRC …

Clinicopathological features and treatment outcomes of metastatic tumors in the stomach

T Namikawa, K Hanazaki - Surgery today, 2014 - Springer
The metastasis of tumors to the stomach is rare, which underlies the clinical problems
regarding their diagnosis and treatment. The present review summarizes the current …

Effect of low-ratio n-6/n-3 PUFA on blood glucose: a meta-analysis

N Li, H Yue, M Jia, W Liu, B Qiu, H Hou, F Huang… - Food & function, 2019 - pubs.rsc.org
Objective: The aim of this meta-analysis was to investigate the effect of increasing dietary
low-ratio n-6/n-3 polyunsaturated fatty acid (PUFA) intake on blood glucose and other …